Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

Medical Care Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.


CSE:PHRX - Post by User

Pharmadrug Inc > There is a new and better Zilla in town now
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3076)
•••
Comment by Goldy63on Aug 30, 2021 12:07pm
44 Views
Post# 33781729

RE:RE:There is a new and better Zilla in town now

RE:RE:There is a new and better Zilla in town now
SamRothstein wrote: I guess you were lying. Again. Frogzilla just posted something.  So he wasn't suspended.  What a shocker that a scumbag like you would make something up like that.  Something that can be so easily proven to be false.  You don't even lie well.

Toadzilla wrote: Frogzilla has been suspended and banished from these boards for cluttering the boards and posting too much mentally deranged garbage bashing other posters. There is a new Zilla in charge now.


ToadZilla is your mentor and supreme leader now.  Forget the Frog.  The Toad is here now.


Pay attention Sam and Goldy to this change.  Your former Frog leader has been replaced.  The Toad is here now.


TZ



Just one more lie of thousands to date  and counting Sam so whats new when it comes to the troll and his many alias . Todays news is another important cog in the big pharma team Dan is building . Love it . Long PHRX.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities